tetano
Editor, Senior Moderator
Arch Virol. 2018 Nov 24. doi: 10.1007/s00705-018-4103-4. [Epub ahead of print]
[h=1]Molecular evolutionary and antigenic characteristics of newly isolated H9N2 avian influenza viruses in Guangdong province, China.[/h] Zhang J[SUP]1[/SUP], Wu H[SUP]1[/SUP], Zhang Y[SUP]1[/SUP], Cao M[SUP]1[/SUP], Brisse M[SUP]2[/SUP], Zhu W[SUP]1,[/SUP][SUP]2[/SUP], Li R[SUP]1[/SUP], Liu M[SUP]1[/SUP], Cai M[SUP]3[/SUP], Chen J[SUP]4[/SUP], Chen J[SUP]5[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Four new H9N2 avian influenza viruses (AIVs) were isolated from domestic birds in Guangdong between December 2015 and April 2016. Nucleotide sequence comparisons indicated that most of the internal genes of these four strains were highly similar to those of human H7N9 viruses. Amino acid substitutions and deletions found in the HA and NA proteins indicated that all four of these new isolates may have an enhanced ability to infect humans and other mammals. A cross-hemagglutinin-inhibition assay, conducted with two vaccine strains that are broadly used in China, suggested that antisera against vaccine candidates could not provide complete inhibition of the new isolates.
PMID: 30474753 DOI: 10.1007/s00705-018-4103-4
[h=1]Molecular evolutionary and antigenic characteristics of newly isolated H9N2 avian influenza viruses in Guangdong province, China.[/h] Zhang J[SUP]1[/SUP], Wu H[SUP]1[/SUP], Zhang Y[SUP]1[/SUP], Cao M[SUP]1[/SUP], Brisse M[SUP]2[/SUP], Zhu W[SUP]1,[/SUP][SUP]2[/SUP], Li R[SUP]1[/SUP], Liu M[SUP]1[/SUP], Cai M[SUP]3[/SUP], Chen J[SUP]4[/SUP], Chen J[SUP]5[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Four new H9N2 avian influenza viruses (AIVs) were isolated from domestic birds in Guangdong between December 2015 and April 2016. Nucleotide sequence comparisons indicated that most of the internal genes of these four strains were highly similar to those of human H7N9 viruses. Amino acid substitutions and deletions found in the HA and NA proteins indicated that all four of these new isolates may have an enhanced ability to infect humans and other mammals. A cross-hemagglutinin-inhibition assay, conducted with two vaccine strains that are broadly used in China, suggested that antisera against vaccine candidates could not provide complete inhibition of the new isolates.
PMID: 30474753 DOI: 10.1007/s00705-018-4103-4